BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totaling 3,486 shares, a growth of 113.3% from the April 15th total of 1,634 shares. Based on an average daily trading volume, of 10,915 shares, the short-interest ratio is currently 0.3 days.
BioPharma Credit Stock Performance
OTCMKTS BOPCF opened at $0.90 on Friday. The company has a 50 day moving average price of $0.93 and a two-hundred day moving average price of $0.90. BioPharma Credit has a 12-month low of $0.83 and a 12-month high of $1.00.
About BioPharma Credit
BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.
Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.
Featured Articles
- Five stocks we like better than BioPharma Credit
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
